Nutritional Status in Children Treated With Advanced Nutrition Therapy
NCT ID: NCT03049826
Last Updated: 2022-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2017-02-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim: This project aims to improve the nutritional therapy to children being treated for cancer and children undergoing stem cell transplantation
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nutrition Childhood Cancer Survivors
NCT05481229
Pilot Test for a Newly Developed Nutrition Screening Method: Pediatric Subjective Global Assessment
NCT00665691
Green Approach to Improved Nutritional Support for Cancer Patients
NCT05544318
Body Composition and Nutritional Status in Pediatric Patients With Hematological Malignancies
NCT04764695
Cancer Patients' Knowledge About Fatigue
NCT00927433
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The subjects are 140 children and adolescents (2-17 years) being treated for cancer and a subgroup of 25 patients treated with SCT at Oslo University. The results will be compared with a reference group of 25 patients treated with home parenteral nutrition as well as 50 healthy reference persons in the same age group.
The methods used for measurement of nutritional status are: Body composition, bone density, blood tests, diet record, activity detection and measurement of quality of life. The measurements are done on three occasions for patients with cancer and stem cell transplantation, and on one occasion with a reference. Information on demographics and medical care will be taken from journal. Growth data will be collected from health centres when needed. Parents' experiences of children's feeding problems will also be examined.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stem cell transplantation (SCT)
Children undergoing stem cell transplantation (SCT)
Nutritional status
Body composition and nutrient status
Home parenteral nutrition (HPN)
Children receiving home parenteral nutrition
No interventions assigned to this group
Healthy reference group
Healthy children
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nutritional status
Body composition and nutrient status
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All patients will be recruited from Oslo University Hospital. Inclusion criteria are age 2 -17 years of age. The SCT and HPN group will include children who have not previously undergone transplantation, who do not have a pacemaker or other implants that prevent the measurement of muscle mass. Participants in the reference groups will be of the same age group, without congenital syndromes or previous cancers.
Exclusion Criteria:
* Exclusion criteria are patients who reject bone marrow
2 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
University of Oslo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christine Henriksen
Assossiate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christine Henriksen, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Oslo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Oslo
Oslo, , Norway
Oslo University Hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AEV2017/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.